Galapagos NV (NASDAQ:GLPG) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

Other analysts have also issued research reports about the company. Janney Montgomery Scott lowered Galapagos NV from a “buy” rating to a “sell” rating in a research report on Monday, April 24th. Nomura dropped their price objective on Galapagos NV from $108.00 to $121.00 and set a “buy” rating on the stock in a report on Thursday, June 22nd. Stifel Nicolaus raised their price objective on Galapagos NV from $65.00 to $83.00 and gave the stock a “hold” rating in a report on Monday, May 1st. Zacks Investment Research lowered Galapagos NV from a “buy” rating to a “hold” rating in a report on Monday, April 24th. Finally, Instinet reaffirmed a “buy” rating and set a $108.00 price objective (down previously from $121.00) on shares of Galapagos NV in a report on Thursday, June 22nd. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Galapagos NV presently has a consensus rating of “Buy” and an average target price of $96.14.

Shares of Galapagos NV (GLPG) traded down 1.12% during midday trading on Thursday, hitting $86.43. The stock had a trading volume of 219,221 shares. Galapagos NV has a 52-week low of $53.01 and a 52-week high of $94.88.

TRADEMARK VIOLATION WARNING: “Galapagos NV (GLPG) Stock Rating Upgraded by BidaskClub” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/08/20/galapagos-nv-glpg-stock-rating-upgraded-by-bidaskclub.html.

Several institutional investors have recently bought and sold shares of the stock. Bogle Investment Management L P DE purchased a new position in shares of Galapagos NV during the first quarter worth approximately $368,000. Airain ltd bought a new stake in Galapagos NV during the first quarter valued at $237,000. Wellington Management Group LLP increased its stake in Galapagos NV by 9.5% in the first quarter. Wellington Management Group LLP now owns 458,088 shares of the biotechnology company’s stock valued at $39,483,000 after buying an additional 39,729 shares during the last quarter. Bank of Montreal Can increased its stake in Galapagos NV by 8,736.4% in the first quarter. Bank of Montreal Can now owns 1,944 shares of the biotechnology company’s stock valued at $168,000 after buying an additional 1,922 shares during the last quarter. Finally, Driehaus Capital Management LLC bought a new stake in Galapagos NV during the first quarter valued at $942,000. Institutional investors and hedge funds own 20.73% of the company’s stock.

Galapagos NV Company Profile

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Analyst Recommendations for Galapagos NV (NASDAQ:GLPG)

Receive News & Ratings for Galapagos NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galapagos NV and related companies with MarketBeat.com's FREE daily email newsletter.